The year-end update is positive. The key highlight is that management navigated the CV19 related period (4 months) successfully, with revenue recovering post the April hit and CVS exiting June with good overall momentum. This means that with a strong 8 months of pre CV19 trading already delivered, the full year revenue outturn is signalled as being “comfortably ahead of last year” vs consensus at -2.0% - a hugely positive outcome. There is favourable balance sheet de-leverage commentary but havi ....
24 Jul 2020
Highly reassuring YE update / positive momentum going into FY21
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Highly reassuring YE update / positive momentum going into FY21
CVS Group plc (CVSG:LON) | 925 -175.8 (-2.0%) | Mkt Cap: 663.4m
- Published:
24 Jul 2020 -
Author:
Sahill Shan -
Pages:
3
The year-end update is positive. The key highlight is that management navigated the CV19 related period (4 months) successfully, with revenue recovering post the April hit and CVS exiting June with good overall momentum. This means that with a strong 8 months of pre CV19 trading already delivered, the full year revenue outturn is signalled as being “comfortably ahead of last year” vs consensus at -2.0% - a hugely positive outcome. There is favourable balance sheet de-leverage commentary but havi ....